• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study.家族性视网膜母细胞瘤:眼底筛查时间表的影响和指南建议。一项回顾性研究。
Eye (Lond). 2011 Dec;25(12):1555-61. doi: 10.1038/eye.2011.198. Epub 2011 Sep 16.
2
Prenatal versus Postnatal Screening for Familial Retinoblastoma.产前与产后筛查家族性视网膜母细胞瘤。
Ophthalmology. 2016 Dec;123(12):2610-2617. doi: 10.1016/j.ophtha.2016.08.027. Epub 2016 Oct 3.
3
Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands.荷兰全国性登记:家族性视网膜母细胞瘤筛查患者的就诊阶段及视觉预后
Br J Ophthalmol. 2006 Jul;90(7):875-8. doi: 10.1136/bjo.2005.089375. Epub 2006 Apr 13.
4
Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).视网膜母细胞瘤的治疗:居里研究所对730例患者(1995年至2009年)的治疗经验。
J Fr Ophtalmol. 2015 Jun;38(6):535-41. doi: 10.1016/j.jfo.2015.04.002. Epub 2015 May 11.
5
Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children.
Ophthalmic Genet. 2020 Aug;41(4):308-314. doi: 10.1080/13816810.2020.1766085. Epub 2020 May 20.
6
Retinoblastoma in a 37-year-old man: Clinical aspect, imaging and histological features.一名37岁男性的视网膜母细胞瘤:临床症状、影像学及组织学特征
J Fr Ophtalmol. 2018 Jun;41(6):e265-e269. doi: 10.1016/j.jfo.2017.09.026. Epub 2018 Jun 15.
7
At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98.家族性视网膜母细胞瘤筛查应在什么年龄停止?一项基于1945年至1998年登记资料的研究。
Br J Ophthalmol. 2000 Oct;84(10):1170-2. doi: 10.1136/bjo.84.10.1170.
8
Loss of fundus view as an indication for secondary enucleation in retinoblastoma.眼底丧失作为视网膜母细胞瘤二次眼球摘除的指征。
Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26908. Epub 2017 Dec 8.
9
[Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision].视网膜母细胞瘤的诊断与治疗:有效控制肿瘤及保留视力的当前策略
Klin Monbl Augenheilkd. 2013 Mar;230(3):232-42. doi: 10.1055/s-0032-1328158. Epub 2013 Mar 18.
10
Knowledge of genetics in familial retinoblastoma.家族性视网膜母细胞瘤的遗传学知识。
Ophthalmic Genet. 2017 May-Jun;38(3):226-232. doi: 10.1080/13816810.2016.1195846. Epub 2016 Jul 18.

引用本文的文献

1
Case Report: A novel germline donor splicing site mutation of gene in a Chinese Tibetan pedigree with familial retinoblastoma.病例报告:在中国藏族一个患有家族性视网膜母细胞瘤的家系中发现一种新的基因种系供体剪接位点突变。
Front Oncol. 2025 May 20;15:1525035. doi: 10.3389/fonc.2025.1525035. eCollection 2025.
2
Bilateral familial retinoblastoma diagnosed via optical coherence tomography following a normal funduscopic exam.在眼底镜检查正常后,通过光学相干断层扫描诊断出双侧家族性视网膜母细胞瘤。
Fam Cancer. 2024 Dec 16;24(1):12. doi: 10.1007/s10689-024-00424-w.
3
At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review.家族性视网膜母细胞瘤筛查在什么年龄可以停止?一项系统评价。
Cancers (Basel). 2021 Apr 17;13(8):1942. doi: 10.3390/cancers13081942.
4
Knudson to embryo selection: A story of the genetics of retinoblastoma.从克努森到胚胎选择:视网膜母细胞瘤遗传学的故事。
Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):196-204. doi: 10.4103/tjo.tjo_37_18.
5
Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.静脉化疗与眼内动脉化疗治疗视网膜母细胞瘤的比较:一项荟萃分析。
BMC Cancer. 2018 Apr 27;18(1):486. doi: 10.1186/s12885-018-4406-6.
6
Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.来自监测、流行病学和最终结果(SEER)登记处的1452例视网膜母细胞瘤的流行病学趋势。
Can J Ophthalmol. 2017 Dec;52(6):592-598. doi: 10.1016/j.jcjo.2017.05.012. Epub 2017 Jul 22.
7
Retinoblastoma: Making a Difference Together.视网膜母细胞瘤:携手创造改变。
Asia Pac J Oncol Nurs. 2017 Jul-Sep;4(3):181-183. doi: 10.4103/apjon.apjon_33_17.
8
Retinoblastoma and Neuroblastoma Predisposition and Surveillance.视网膜母细胞瘤和神经母细胞瘤的易感性和监测。
Clin Cancer Res. 2017 Jul 1;23(13):e98-e106. doi: 10.1158/1078-0432.CCR-17-0652.
9
Management of familial cancer: sequencing, surveillance and society.家族性癌症的管理:测序、监测和社会。
Nat Rev Clin Oncol. 2014 Dec;11(12):723-31. doi: 10.1038/nrclinonc.2014.169. Epub 2014 Oct 14.
10
Preserving vision in retinoblastoma through early detection and intervention.通过早期检测和干预来保护视网膜母细胞瘤患者的视力。
Curr Oncol Rep. 2012 Apr;14(2):213-9. doi: 10.1007/s11912-012-0226-z.

本文引用的文献

1
Familial retinoblastoma in developing countries.发展中国家的家族性视网膜母细胞瘤
Pediatr Blood Cancer. 2009 Sep;53(3):338-42. doi: 10.1002/pbc.21970.
2
Conservative treatments of intraocular retinoblastoma.眼内视网膜母细胞瘤的保守治疗
Ophthalmology. 2008 Aug;115(8):1405-10, 1410.e1-2. doi: 10.1016/j.ophtha.2007.11.009. Epub 2008 Jan 25.
3
Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963 to 2004.1963年至2004年接受治疗的瑞士视网膜母细胞瘤患者的诊断时间缩短,就诊时分期改善。
Pediatrics. 2006 Nov;118(5):e1493-8. doi: 10.1542/peds.2006-0784. Epub 2006 Sep 25.
4
The International Classification of Retinoblastoma predicts chemoreduction success.视网膜母细胞瘤国际分类法可预测化疗减瘤的成功率。
Ophthalmology. 2006 Dec;113(12):2276-80. doi: 10.1016/j.ophtha.2006.06.018. Epub 2006 Sep 25.
5
Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands.荷兰全国性登记:家族性视网膜母细胞瘤筛查患者的就诊阶段及视觉预后
Br J Ophthalmol. 2006 Jul;90(7):875-8. doi: 10.1136/bjo.2005.089375. Epub 2006 Apr 13.
6
Intraocular retinoblastoma: the case for a new group classification.眼内视网膜母细胞瘤:一种新的分组分类方法
Ophthalmol Clin North Am. 2005 Mar;18(1):41-53, viii. doi: 10.1016/j.ohc.2004.11.003.
7
Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.里瑟-埃尔斯沃思Vb组视网膜母细胞瘤患者初次外照射放疗后的结果
Arch Ophthalmol. 2004 Sep;122(9):1316-23. doi: 10.1001/archopht.122.9.1316.
8
Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.视网膜母细胞瘤后二次恶性肿瘤的结局:对居里研究所治疗的25例患者的回顾性分析。
Eur J Cancer. 2004 Jul;40(10):1522-9. doi: 10.1016/j.ejca.2004.03.023.
9
Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival.视网膜母细胞瘤的筛查:呈现的体征作为患者和眼部生存的预后指标。
Pediatrics. 2003 Dec;112(6 Pt 1):1248-55. doi: 10.1542/peds.112.6.1248.
10
Chemothermotherapy in the management of retinoblastoma.视网膜母细胞瘤治疗中的化学热疗法
Ophthalmology. 2002 Jun;109(6):1130-6. doi: 10.1016/s0161-6420(02)01053-9.

家族性视网膜母细胞瘤:眼底筛查时间表的影响和指南建议。一项回顾性研究。

Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study.

机构信息

Department of Ocular Oncology, Institut Curie, Paris, France.

出版信息

Eye (Lond). 2011 Dec;25(12):1555-61. doi: 10.1038/eye.2011.198. Epub 2011 Sep 16.

DOI:10.1038/eye.2011.198
PMID:21921957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3234459/
Abstract

AIMS

To assess if systematic fundus screening according to an 'intensive' schedule alters ocular outcome and to propose fundus screening schedule guidelines for children related to a retinoblastoma patient.

METHODS

For children with a positive family history of retinoblastoma, we perform fundus exams shortly after birth under general anaesthesia and then at regular intervals according to schedules based on the risk. Familial retinoblastoma cases seen at our institution from January 1995 to December 2004 were retrospectively classified as 'screened' or 'non-screened' (NS) and, among the 'screened' patients, as 'intensively screened' (IS) if screening matched our recommendations or 'non-intensively screened' (S). Groups were compared by Fisher exact test for categorical variables and Kruskal-Wallis test for continuous variables.

RESULTS

Among the 547 retinoblastoma patients managed at our institution during this period, 59 were familial cases. In all, 20 were in the NS group, 23 in the S group, and 16 in the IS group. The number of children enucleated was, respectively, 13, 2, and 0 (P<10(-4)); external beam radiation (EBRT) was required for, respectively, 6, 0, and 2 children (P<0.009). Chemotherapy burden and visual acuity were not significantly different between groups.

CONCLUSION

An 'intensive' fundus screening schedule decreased the need for enucleation and EBRT. Therefore, despite the heavy burden of the screening schedule, we recommend physicians and health-care professionals to better inform and refer children with a family history of retinoblastoma for genetic counselling and proper fundus screening in specialized centres.

摘要

目的

评估根据“强化”方案进行系统性眼底筛查是否会改变眼部结局,并为与视网膜母细胞瘤患者相关的儿童提出眼底筛查方案指南。

方法

对于有阳性家族史的儿童,我们在全身麻醉下出生后不久进行眼底检查,然后根据风险制定的时间表定期进行检查。本机构于 1995 年 1 月至 2004 年 12 月期间回顾性地将家族性视网膜母细胞瘤病例分为“筛查”或“未筛查”(NS),在“筛查”患者中,如果筛查符合我们的建议,则分为“强化筛查”(IS)或“非强化筛查”(S)。通过 Fisher 确切检验比较分类变量,通过 Kruskal-Wallis 检验比较连续变量。

结果

在本机构管理的 547 例视网膜母细胞瘤患者中,有 59 例为家族性病例。在所有病例中,20 例为 NS 组,23 例为 S 组,16 例为 IS 组。分别有 13、2 和 0 例患儿需要行眼球摘除术(P<10(-4));分别有 6、0 和 2 例患儿需要行外照射放疗(EBRT)(P<0.009)。各组间化疗负担和视力无显著差异。

结论

“强化”眼底筛查方案减少了眼球摘除术和 EBRT 的需求。因此,尽管筛查方案负担沉重,但我们建议医生和医疗保健专业人员更好地告知和转介有视网膜母细胞瘤家族史的儿童进行遗传咨询,并在专门中心进行适当的眼底筛查。